PRQR
ProQR Therapeutics BV
1.60$
-3.7%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | 100.0% | – | – | 100.0% | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 5,243.0% | 376.3% | 2,563.8% | 3,723.9% | – | – | 2,497.8% | 313,277,112.1% | 129,043,848,924.9% | 0.0% | 0.0% | – | – | 6,043.6% | – | – | – | – | – | – | – | – | – | – | – | 58.9% | – | – | – | – | 15.6% | 11.3% | – | – | – | – | – | 14.5% | 34.1% | 8.1% | – | |
| -268.2% | 100.0% | 65.0% | -200.9% | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 280.3% | – | – | -5,943.6% | – | – | 100.0% | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 85.5% | 65.9% | 91.9% | 88.7% | |
| 3,730.5% | 355.0% | 1,911.9% | 2,281.6% | – | – | 1,251.9% | 597.7% | 183.9% | 193.1% | 2,875.7% | – | – | 720.7% | – | – | 3,308.4% | – | – | 1,488.5% | 960.6% | 5,211.7% | 1,085.9% | 1,112.6% | 1,728.8% | 883.5% | 869.4% | 475.4% | 397.5% | 235.5% | 208.6% | 111.8% | 245.0% | 246.4% | 272.7% | 298.9% | 380.1% | 211.6% | 581.9% | 144.6% | 247.2% | |
| 897.3% | 99.0% | 548.6% | 873.7% | – | – | 435.3% | 264.3% | 75.3% | 93.9% | 767.1% | – | – | 202.6% | – | – | 1,119.1% | – | – | 630.3% | 396.5% | 2,224.3% | 398.7% | 525.9% | 603.5% | 245.4% | 577.6% | 333.5% | 242.0% | 144.6% | 77.6% | 47.8% | 85.4% | 90.9% | 71.6% | 126.2% | 107.0% | 83.8% | 186.4% | 55.2% | 85.1% | |
| 4,627.8% | 454.0% | 2,395.5% | 3,108.8% | – | – | 1,687.2% | 776.2% | 259.2% | 287.0% | 3,642.8% | – | – | 901.4% | – | – | 4,327.5% | – | – | 2,118.8% | 1,357.1% | 7,436.0% | 1,484.6% | 1,638.6% | 2,332.3% | 1,128.9% | 1,447.1% | 808.8% | 639.5% | 290.9% | 281.5% | 157.1% | 326.8% | 334.1% | 339.3% | 420.9% | 487.1% | 280.2% | 737.2% | 192.6% | 321.6% | |
| -4,427.4% | -449.5% | -2,366.9% | -3,075.2% | – | – | -1,605.9% | -765.2% | -172.8% | -260.0% | -3,542.8% | – | – | -901.4% | – | – | -4,327.5% | – | – | -2,018.8% | -1,257.1% | -7,250.2% | -1,384.6% | -1,538.6% | -2,232.3% | -1,028.9% | -1,347.1% | -708.8% | -539.5% | -190.9% | -181.5% | -57.1% | -226.8% | -234.1% | -239.3% | -320.9% | -387.1% | -194.6% | -671.4% | -100.7% | -233.0% | |
| 113.9% | 11.7% | 127.9% | 357.7% | – | – | 139.9% | 8.6% | 2.2% | 3.0% | 357.8% | – | – | 85.8% | – | – | 742.2% | – | – | 376.8% | – | 7.9% | 66.8% | 11.6% | 69.8% | 101.4% | 78.0% | 0.1% | 0.8% | 8.4% | 0.1% | 0.0% | – | – | – | – | – | – | – | – | – | |
| -4,541.3% | -386.5% | -2,494.8% | -3,432.9% | – | – | -1,745.9% | -738.4% | -175.0% | -262.6% | -3,424.0% | – | – | -957.6% | – | – | -5,224.7% | – | – | -2,400.6% | -1,298.3% | -7,622.6% | -1,146.2% | -1,308.4% | -2,616.6% | -1,098.3% | -1,270.4% | -638.4% | -392.6% | -166.8% | -172.0% | -45.9% | -211.0% | -216.0% | -223.0% | -318.6% | -377.6% | -190.3% | -658.3% | -99.4% | -228.2% | |
| 113.9% | -63.0% | 0.5% | 357.7% | – | – | -9.4% | 0.1% | -1.0% | -1.2% | -20.9% | – | – | 3.5% | – | – | 29.9% | – | – | 8.1% | 3.0% | 9.2% | 0.6% | 1.9% | 7.8% | -62.6% | -124.0% | 3.4% | 3.0% | 0.2% | 0.1% | -3.2% | – | – | – | 0.5% | – | 0.0% | 0.0% | 0.3% | – | |
| -4,541.3% | -386.5% | -2,495.2% | -3,432.9% | – | – | -1,736.4% | -732.7% | -174.0% | -262.0% | -3,403.1% | – | – | -958.9% | – | – | -5,251.4% | – | – | -2,407.6% | -1,299.4% | -7,623.8% | -1,146.1% | -1,331.4% | -2,625.9% | -1,098.0% | -1,281.6% | -643.0% | -416.8% | -167.0% | -172.1% | -42.7% | -211.0% | -216.0% | -223.0% | -319.1% | -377.6% | -190.3% | -658.3% | -99.6% | -228.4% | |
| -4,500.4% | -318.0% | -2,396.7% | -3,026.6% | – | – | -1,648.1% | -751.9% | -165.8% | -164.7% | -3,417.5% | – | – | -698.0% | – | – | -4,168.1% | – | – | -1,931.8% | -1,251.3% | -7,105.0% | -1,033.1% | -1,250.9% | -2,547.6% | -980.7% | -1,113.6% | -590.7% | -345.0% | -8.9% | -156.4% | -34.6% | -212.5% | -135.2% | -208.0% | -300.9% | -354.5% | -180.2% | -624.2% | -92.6% | -215.1% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.